Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable
Prophylaxis of RhD negative mothers with anti-D immunoglobulin after childbirth is the most important procedure reducing the immunization of the mother and the risk of severe hemolytic disease of the newborn. In spite of this, anti-D antibodies having relevance to pregnancy are later detected in 1.8% of RhD negative mothers. Half of these cases could be prevented by routine anti-D prophylaxis given to the mothers during weeks 28 to 34 of pregnancy. Convincing evidence of the effectiveness of this measure has accumulated in the last few years, and application of the treatment is justified also in Finland.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:128 |
---|---|
Enthalten in: |
Duodecim; laaketieteellinen aikakauskirja - 128(2012), 2 vom: 25., Seite 151-7 |
Sprache: |
Finnisch |
---|
Weiterer Titel: |
Vastasyntyneen hemolyyttinen tauti ei ole hävinnyt Suomesta |
---|
Beteiligte Personen: |
Sainio, Susanna [VerfasserIn] |
---|
Themen: |
English Abstract |
---|
Anmerkungen: |
Date Completed 05.04.2012 Date Revised 29.02.2012 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM21578328X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM21578328X | ||
003 | DE-627 | ||
005 | 20231224030235.0 | ||
007 | tu | ||
008 | 231224s2012 xx ||||| 00| ||fin c | ||
028 | 5 | 2 | |a pubmed24n0719.xml |
035 | |a (DE-627)NLM21578328X | ||
035 | |a (NLM)22372070 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fin | ||
100 | 1 | |a Sainio, Susanna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable |
246 | 3 | 3 | |a Vastasyntyneen hemolyyttinen tauti ei ole hävinnyt Suomesta |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 05.04.2012 | ||
500 | |a Date Revised 29.02.2012 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Prophylaxis of RhD negative mothers with anti-D immunoglobulin after childbirth is the most important procedure reducing the immunization of the mother and the risk of severe hemolytic disease of the newborn. In spite of this, anti-D antibodies having relevance to pregnancy are later detected in 1.8% of RhD negative mothers. Half of these cases could be prevented by routine anti-D prophylaxis given to the mothers during weeks 28 to 34 of pregnancy. Convincing evidence of the effectiveness of this measure has accumulated in the last few years, and application of the treatment is justified also in Finland | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a Isoantibodies |2 NLM | |
650 | 7 | |a Rho(D) Immune Globulin |2 NLM | |
700 | 1 | |a Kuosmanen, Malla |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Duodecim; laaketieteellinen aikakauskirja |d 1945 |g 128(2012), 2 vom: 25., Seite 151-7 |w (DE-627)NLM000016136 |x 0012-7183 |7 nnns |
773 | 1 | 8 | |g volume:128 |g year:2012 |g number:2 |g day:25 |g pages:151-7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 128 |j 2012 |e 2 |b 25 |h 151-7 |